Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Male Pattern Baldness: early-phase trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Male Pattern Baldness: 4 US clinical trials tracked, none currently recruiting.
Male Pattern Baldness is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Veradermics, running 3 of these trials.
Enrollment posture brief
Registry condition male-pattern-baldness
OPEN 0 | RECR 0% | LATE 1 | EARLY 3 | RANK #4115 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Male Pattern Baldness has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Male Pattern Baldness on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Male Pattern Baldness is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Efficacy and Safety of VDPHL01 in Males With AGA
Veradermics
NCT06724614
Safety and Efficacy of VDPHL01 in Males With AGA
Veradermics
NCT06972264
Safety and Efficacy of VDPHL01 in Males and Females With AGA
Veradermics
NCT06527365
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
Aderans Research Institute
NCT01451151
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Male Pattern Baldness records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Male Pattern Baldness trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Male Pattern Baldness page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Male Pattern Baldness trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Veradermics sponsors the most Male Pattern Baldness trials on record, review their full trial history before evaluating a specific study. See Veradermics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Male Pattern Baldness condition card totals 4 registered trials; most-linked intervention VDPHL01; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.